Berrak zihinler için yalın, zengin, bağımsız bir Türkçe dijital medya üyeliği.
Ücretsiz Kaydol →
alzheimers ile ilgili hikayeler
• Biogen shares surged more than 35% as the new Alzheimer’s drug it developed with Japan’s Eisai was hailed as an “unequivocal win” by analysts at a late-stage clinical trial, adding more than $10 billion to its market capitalization and putting it on track to erase all of its losses this year. Biogen The trial: Biogen and Eisai said their experimental drug, lecanemab, slowed the progress of the disease by 27% compared with a placebo, in a large trial of pati...Devamını Oku
29 Eyl 2022